GARS1 and neoplasm: Additionally, our study revealed that GARS1 is linked to several immune-regulated signaling pathways, including MYC_TARGETS_V1, MYC_TARGETS_V2, and E2F_TARGETS, providing further evidence of the strong connection between GARS1 and tumor immunity.